Abstract
This Viewpoint discusses the ongoing lawsuit between plaintiffs who had been affected by atypical femoral fractures while receiving alendronate and the drug manufacturer.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have